Results 121 to 130 of about 64,234 (265)

Primary care approach to alopecia in adult patients. [PDF]

Singapore Med J
Cheung YS, Ng IKS, Long VS, Goh LH, Chandran NS.   +4 more
europepmc   +1 more source

The benefits of multidisciplinary collaboration in the successful management of two complex feline cases

Australian Veterinary Journal, EarlyView.
Despite a frequent misconception that behavioural concerns are diagnoses of exclusion, medical conditions and behavioural disorders are frequently inter‐related. In human medicine, the ‘multidisciplinary team’ approach (MDTA) is considered the most efficacious way of managing patients with complex and chronic health conditions.
BE Bollaert, JM Ley, HE Zulch
wiley   +1 more source

Current Management and Unmet Needs in Alopecia Areata: Viewpoint From a Malaysian Perspective. [PDF]

JMIR Dermatol
Mohd Affandi A, Jamil A, Azizan NZ, Yap FB, Leong KF, Heng AYH, Nuraihan S, Tan WC, Selvarajah L, Raja T, Yap EWY, Ch'ng PWB, Teoh TY, Tey MY.   +13 more
europepmc   +1 more source

Rare Case of Alopecia: Alopecia Neoplastica

International Journal of Trichology
Dhiman, Avita, Chauhan, Payal, Dhiman, Pravesh, Shilpi, Shilpi, Daroach, Manju   +4 more
openaire   +3 more sources

Ocular and cutaneous infection due to Curvularia pseudobrachyspora in an immunosuppressed dog: Case report and in vitro antimycotic susceptibilities

Australian Veterinary Journal, EarlyView.
A 3‐year‐old male Border Collie diagnosed with immune‐mediated dermatopathy, managed with tapering prednisolone and cyclosporine, developed rapidly progressive ocular signs and additional cutaneous lesions. Histopathology, mycological culture, polymerase chain reaction and sequencing confirmed intraocular and cutaneous infection due to Curvularia ...
T Brasil‐Ervedosa, R Clark, J Granados‐Soler, C Palmieri, V Gonzalez‐Astudillo   +4 more
wiley   +1 more source

Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats. [PDF]

Front Vet Sci
Seo J, Yun JH.
europepmc   +1 more source

Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma: Phase 1b dose‐escalation study

British Journal of Haematology, EarlyView.
Summary Glofitamab was investigated with obinutuzumab/rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (G/R‐CHOP) in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma (B‐NHL) who had ≥1 prior obinutuzumab/rituximab‐containing therapy (NCT03467373). The primary end‐point was to determine the optimal biological dose of
William Townsend, Nilanjan Ghosh, Martin Hutchings, Michael Dickinson, Monica Tani, Armando Santoro, Michael Crump, Amitkumar Mehta, Reinhard Marks, Martin Weisser, Martin Barrett, Chun Wu, Derrick Kaufman, Katharina Lechner, Pauline Baumlin, Pontus Lundberg, Max S. Topp   +16 more
wiley   +1 more source

'Cutting Through the Roots': A Critical Appraisal of Transverse and Vertical Sectioning Techniques of Scalp Biopsy for Primary Alopecia. [PDF]

Indian J Dermatol
Palo S.
europepmc   +1 more source

Isoniazid and alopecia

Lung India, 2011
Somsri Wiwanitkit, Viroj Wiwanitkit
openaire   +3 more sources

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

British Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown, Alan Armstrong, David J. Mann   +2 more
wiley   +1 more source